Yi Liu

机构：China-Japan Friendship Hospital, Beijing Friendship Hospital, Chengdu University of Traditional Chinese Medicine · ORCID：0000-0002-4295-1440

发表论文 34 篇 · 总被引 565 次 · h-index 13

代表论文

• Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk (2024 · Frontiers in Immunology · 被引 98)
• Natural Products Modulate Cell Apoptosis: A Promising Way for the Treatment of Ulcerative Colitis (2022 · Frontiers in Pharmacology · 被引 56)
• Polygonum multiflorum-Induced Liver Injury: Clinical Characteristics, Risk Factors, Material Basis, Action Mechanism and Current Challenges (2019 · Frontiers in Pharmacology · 被引 52)
• Hepatic cytochromes P450: structural degrons and barcodes, posttranslational modifications and cellular adapters in the ERAD-endgame (2016 · Drug Metabolism Reviews · 被引 32)
• Isoliquiritigenin attenuates emodin-induced hepatotoxicity in vivo and in vitro through Nrf2 pathway (2022 · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · 被引 25)
• Traditional Chinese medicine in treating ischemic stroke by modulating mitochondria: A comprehensive overview of experimental studies (2023 · Frontiers in Pharmacology · 被引 19)